The largest database of trusted experimental protocols

2 protocols using anti iκbα p iκbα

1

Protein Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
After lysing cells with RIPA (Beyotime, Shanghai, China) to obtain protein samples, protein concentration was measured using the BCA method. After electrophoresis, 5% skimmed milk was blocked for 2 h at room temperature, the primary antibody was incubated overnight at 4 °C, and the secondary antibody was incubated for 1 h at room temperature; anti-p38/p-p38, anti-ERK/p-ERK, anti-JNK/p-JNK, anti-p65/p-p65, anti-IKKα/p-IKKα, anti-IκBα/p-IκBα, anti-Sirt1, anti-β-Actin, anti-β-Catenin were obtained from Cell Signalling Technology (1:1000 dilution); anti-PGC1α, anti-COX15, anti-NDUFV2, anti-ATP5D, anti-ATP5H were obtained from Proteintech Biotechnology (1:1000 dilution); anti-TFAM was obtained from Absin Bioscience (1:1000 dilution); anti-p-GSK3β/GSK3β was purchased from Santa Cruz Biotechnology (1:1000 dilution); Peroxidase-conjugated secondary antibody (1:4000 dilution) was used, and ECL reagent (Beyotime, Shinghai, China) was added at a 1:1 ratio to develop the image on a digital imaging system (Bio-Rad, USA).
+ Open protocol
+ Expand
2

Comprehensive Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted using RIPA buffer (Beyotime, Shanghai, China) containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor cocktail. Protein concentrations were determined by the BCA protein assay. Total proteins (40 μg) were separated by SDS-PAGE and blotted onto PVDF membranes (Millipore, Massachusetts, USA). After blocking with 5% BSA in TBST, the membranes were incubated with the following primary antibodies at 4 °C overnight; anti-CD9, anti-CD63, anti-TSG101, anti-VDAC, anti-LAMP1 were obtained from Abcam (Abcam, USA); and anti-p38/p-p38, anti-ERK/p-ERK, anti-JNK/p-JNK, anti-p65/p-p65, anti-IKKα/p-IKKα, anti-Iκbα/p-Iκbα, anti-Sirt1, anti-GAPDH, anti-β-actin were obtained from Cell Signaling Technology (CST, USA); and anti-PGC1α, anti-cox15, anti-NDUFV2, anti-ATP5D, anti-ATP5H were obtained from Proteintech Biotechnology (Proteintech, USA); and anti-TFAM was obtained from Absin Bioscience (Absin, Shanghai, China); and anti-TOM20, anti-CALR were obtained from Santa Cruz Biotechnology (Santa Cruz, USA). Thereafter, the membranes were incubated with HRP-conjugated anti-mouse and anti-rabbit IgG (1:4000, CST, USA), respectively, at room temperature for 1 h. ECL reagent was used to develop the membrane and signal was detected on a digital image system (Bio-Rad, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!